Statements (48)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:drug
|
| gptkbp:bfsLayer |
6
|
| gptkbp:bfsParent |
gptkb:Haemophilus_influenzae
|
| gptkbp:activities |
broad-spectrum
inhibits bacterial cell wall synthesis |
| gptkbp:appointed_by |
injection
|
| gptkbp:approves |
gptkb:1982
gptkb:FDA |
| gptkbp:belongs_to |
cephalosporin class
|
| gptkbp:brand |
Rocephin
|
| gptkbp:category |
B
compatible |
| gptkbp:community_service |
gptkb:battle
|
| gptkbp:contraindication |
allergy to cephalosporins
|
| gptkbp:developed_by |
gptkb:Hoffmann-La_Roche
|
| gptkbp:excretion |
kidneys
|
| https://www.w3.org/2000/01/rdf-schema#label |
ceftriaxone
|
| gptkbp:ingredients |
C18 H18 N8 O7 S
|
| gptkbp:interacts_with |
calcium
|
| gptkbp:is_available_on |
generic drug
|
| gptkbp:is_compatible_with |
calcium-containing solutions
|
| gptkbp:is_tested_for |
required
|
| gptkbp:is_used_for |
bacterial infections
|
| gptkbp:lifespan |
6 to 8 hours
|
| gptkbp:manager |
intravenous
intramuscular |
| gptkbp:metabolism |
liver
|
| gptkbp:notable_work |
pharmacokinetics
antibiotic resistance adverse effects pharmacodynamics therapeutic uses drug interactions clinical efficacy safety profile dosing regimens pharmacokinetics in special populations |
| gptkbp:shelf_life |
24 months
|
| gptkbp:side_effect |
nausea
diarrhea rash |
| gptkbp:storage |
room temperature
|
| gptkbp:used_in |
gptkb:healthcare_organization
meningitis sepsis skin infections urinary tract infections |
| gptkbp:weight |
661.7 g/mol
|